STAAR Surgical Cash on Hand 2012-2026 | STAA
STAAR Surgical cash on hand from 2012 to 2026. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
|
STAAR Surgical Annual Cash on Hand (Millions of US $) |
|
|---|---|
| 2025 | $188 |
| 2024 | $230 |
| 2023 | $221 |
| 2022 | $212 |
| 2021 | $200 |
| 2020 | $152 |
| 2019 | $120 |
| 2018 | $104 |
| 2017 | $19 |
| 2016 | $14 |
| 2015 | $13 |
| 2014 | $13 |
| 2013 | $23 |
| 2012 | $22 |
| 2011 | $17 |
|
STAAR Surgical Quarterly Cash on Hand (Millions of US $) |
|
|---|---|
| 2026-06-30 | $181 |
| 2026-03-31 | $164 |
| 2025-12-31 | $188 |
| 2025-09-30 | $193 |
| 2025-06-30 | $190 |
| 2025-03-31 | $223 |
| 2024-12-31 | $230 |
| 2024-09-30 | $236 |
| 2024-06-30 | $235 |
| 2024-03-31 | $245 |
| 2023-12-31 | $221 |
| 2023-09-30 | $188 |
| 2023-06-30 | $192 |
| 2023-03-31 | $204 |
| 2022-12-31 | $212 |
| 2022-09-30 | $211 |
| 2022-06-30 | $202 |
| 2022-03-31 | $193 |
| 2021-12-31 | $200 |
| 2021-09-30 | $196 |
| 2021-06-30 | $173 |
| 2021-03-31 | $162 |
| 2020-12-31 | $152 |
| 2020-09-30 | $128 |
| 2020-06-30 | $116 |
| 2020-03-31 | $111 |
| 2019-12-31 | $120 |
| 2019-09-30 | $112 |
| 2019-06-30 | $103 |
| 2019-03-31 | $102 |
| 2018-12-31 | $104 |
| 2018-09-30 | $102 |
| 2018-06-30 | $21 |
| 2018-03-31 | $21 |
| 2017-12-31 | $19 |
| 2017-09-30 | $16 |
| 2017-06-30 | $13 |
| 2017-03-31 | $14 |
| 2016-12-31 | $14 |
| 2016-09-30 | $14 |
| 2016-06-30 | $13 |
| 2016-03-31 | $9 |
| 2015-12-31 | $13 |
| 2015-09-30 | $16 |
| 2015-06-30 | $15 |
| 2015-03-31 | $11 |
| 2014-12-31 | $13 |
| 2014-09-30 | $18 |
| 2014-06-30 | $19 |
| 2014-03-31 | $21 |
| 2013-12-31 | $23 |
| 2013-09-30 | $23 |
| 2013-06-30 | $20 |
| 2013-03-31 | $19 |
| 2012-12-31 | $22 |
| 2012-09-30 | $20 |
| 2012-06-30 | $18 |
| 2012-03-31 | $16 |
| 2011-12-31 | $17 |
| 2011-09-30 | $17 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $1.125B | $0.239B |
| Staar Surgical Company has evolved to become a developer, manufacturer and global distributor of products used by ophthalmologists and other eye care professionals to improve or correct vision in patients suffering from refractive conditions, cataracts and glaucoma. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $104.880B | 22.04 |
| Cardinal Health (CAH) | United States | $54.109B | 20.66 |
| Becton Dickinson (BDX) | United States | $51.228B | 14.30 |
| West Pharmaceutical Services (WST) | United States | $25.687B | 42.94 |
| Straumann Holding AG (SAUHY) | Switzerland | $18.592B | 0.00 |
| Align Technology (ALGN) | United States | $10.528B | 16.28 |
| Cooper (COO) | United States | $10.130B | 11.56 |
| Henry Schein (HSIC) | United States | $9.754B | 16.48 |
| Merit Medical Systems (MMSI) | United States | $5.146B | 23.48 |
| DENTSPLY SIRONA (XRAY) | United States | $1.960B | 6.87 |
| CONMED (CNMD) | United States | $1.406B | 9.82 |
| Pro-Dex (PDEX) | United States | $0.214B | 19.97 |
| Lifevantage (LFVN) | United States | $0.077B | 11.04 |